IL6 and metabolic dysfunction-associated steatohepatitis: Both adipokines such as leptin, adiponectin, visfatin and proinflammatory cytokines such as tumor necrosis factor α (TNFα), interleukin-6 (IL-6) and IL-1β could act as pathogenic factors in NASH development [4–7].